Dual Role Played by Ionic Liquids to Modulate the Interfacial and Micellar Properties of the Single-Chain Cationic Surfactants in Aqueous Solution

Author(s):  
Chenhao Jiang ◽  
Hongye Cheng ◽  
Zexian Qin ◽  
Ruizhuan Wang ◽  
Lifang Chen ◽  
...  

2011 ◽  
Vol 2 (18) ◽  
pp. 2331-2336 ◽  
Author(s):  
Niraj Modi ◽  
Pratik Raj Singh ◽  
Kozhinjampara R. Mahendran ◽  
Robert Schulz ◽  
Mathias Winterhalter ◽  
...  

The Analyst ◽  
2004 ◽  
Vol 129 (10) ◽  
pp. 890 ◽  
Author(s):  
Gary A. Baker ◽  
Siddharth Pandey ◽  
Shubha Pandey ◽  
Sheila N. Baker

Author(s):  
Huihui Li ◽  
Yosuke Imai ◽  
Takanori Takiue ◽  
Hiroki Matsubara ◽  
Makoto Aratono

Author(s):  
Justyna Łuczak ◽  
Jan Hupka ◽  
Jorg Thöming ◽  
Christian Jungnickel

Langmuir ◽  
2013 ◽  
Vol 29 (8) ◽  
pp. 2536-2545 ◽  
Author(s):  
M. Teresa Garcia ◽  
Isabel Ribosa ◽  
Lourdes Perez ◽  
Angeles Manresa ◽  
Francesc Comelles

2017 ◽  
Vol 3 (2) ◽  
pp. 695-698
Author(s):  
Andreas Brietzke ◽  
Christian von der Ehe ◽  
Sabine Illner ◽  
Claudia Matschegewski ◽  
Niels Grabow ◽  
...  

AbstractFor the development of intelligent implant systems hydrogels (HG) from crosslinked ionic liquids feature a high potential to be utilised as a drug depot. Biocompatibility of the HGs is one key prerequisite for biomedical applications. HGs were polymerised from a variety of different ionic monomers based on methacrylate, methacrylamide, styrene or vinyl imidazolium derivatives in aqueous solution. N,N'-methylenebisacrylamide was used as crosslinker. CellQuanti-Blue™ Cell Viability Assay Kit was implemented to proof viability of L929 mouse fibroblasts. The predominant part of the HG eluates generated only a marginal reduction of less than 15% cell viability at 100% eluate concentration. This underlines the excellent suitability of these HGs for biomedical applications and revealed some promising candidates for the development of drug depots for implants.


Sign in / Sign up

Export Citation Format

Share Document